Your browser doesn't support javascript.
loading
Multi-organ abnormalities assessed by a single MRI scan in individuals with blood cancer.
Reed, Sophie; Pansini, Michele; Diamond, Charlie; Banerjee, Amitava; Thomaides Brears, Helena; Chowdhury, Onima.
Afiliación
  • Reed S; Oxford University Hospitals' NHS Foundation Trust, Oxford, UK; Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, NIHR, Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Pansini M; Oxford University Hospitals' NHS Foundation Trust, Oxford, UK; Clinica Di Radiologia EOC, Istituto Di Imaging Della Svizzera Italiana (IIMSI), Lugano, Switzerland.
  • Diamond C; Perspectum Ltd, Gemini One, 5520 John Smith Drive, Oxford, UK.
  • Banerjee A; Institute of Health Informatics, University College London, London, UK; Department of Cardiology, University College London Hospitals NHS Foundation Trust, London, UK; Department of Cardiology, Barts Health NHS Trust, London, UK.
  • Thomaides Brears H; Perspectum Ltd, Gemini One, 5520 John Smith Drive, Oxford, UK.
  • Chowdhury O; Oxford University Hospitals' NHS Foundation Trust, Oxford, UK; Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, NIHR, Biomedical Research Centre, University of Oxford, Oxford, UK. Electronic address: onima.chowdhury@ndcls.ox.ac.uk.
Eur J Intern Med ; 128: 150-152, 2024 Oct.
Article en En | MEDLINE | ID: mdl-38796311
ABSTRACT

BACKGROUND:

During the COVID-19 pandemic individuals with all blood cancers were classified as clinically vulnerable and at high risk of complications and death. Our study sought to determine if individuals with specific blood cancers were at a heightened risk of longer term organ impairment, secondary to SARS-CoV-2 infection.

METHODS:

We set up a prospective observational study, utilising quantitative multi-parametric MRI to determine organ health over time in patients with specific blood cancers who had recovered from COVID-19.

RESULTS:

Multi-organ abnormality was more prevalent in blood cancer patients than in healthy controls (42 % vs 6 % p < 0.001) but comparable to the long COVID controls (42 % vs 33 %, p > 0.05). At 6 month follow up scans, organ abnormalities persisted in most individuals with blood cancer (71 % ≥1 organ and 52 % multi-organ).

CONCLUSION:

A multi-organ MRI platform offers the capacity to accurately evaluate organ health dynamically in blood cancers and detect asymptomatic organ impairment. The application of multi-organ MRI could aid early detection and longitudinal monitoring of organ impairment, potentially guiding more personalised treatment strategies and improving clinical outcomes in many rare diseases.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / COVID-19 Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / COVID-19 Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos